C M Bidwell & Associates LTD Amgen Inc Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $230 - $256	-1 Reduced 0.29%	344 $84,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $68,613 - $78,522	345 New	345 $78,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $158,936 - $204,288	-840 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $146,252 - $175,240	840 New	840 $163,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.